Evidence map›Paper›PMID 34403333›Full record

ArticleeLife2021

An in vitro stem cell model of human epiblast and yolk sac interaction.

Kirsty Ml Mackinlay, Bailey At Weatherbee, Viviane Souza Rosa, Charlotte E Handford, George Hudson, Tim Coorens, Lygia V Pereira, Sam Behjati, Ludovic Vallier, Marta N Shahbazi and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The year in review: 2024 signals a new era in reproductive medicine.Journal of assisted reproduction and genetics · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Kirsty Ml MackinlayMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.ORCID 0000-0001-6276-4274
Bailey At WeatherbeeMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.ORCID 0000-0002-6825-6278
Viviane Souza RosaMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
Charlotte E HandfordMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
George HudsonMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.ORCID 0000-0003-2506-6965
Tim CoorensWellcome Sanger Institute, Cambridge, United Kingdom.
Lygia V PereiraNational Laboratory for Embryonic Stem Cells (LaNCE), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
Sam BehjatiWellcome Sanger Institute, Cambridge, United Kingdom.
Ludovic VallierWellcome - MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, United Kingdom.ORCID 0000-0002-3848-2602
Marta N ShahbaziMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.ORCID 0000-0002-1599-5747
Magdalena Zernicka-GoetzMammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.ORCID 0000-0002-7004-2471
University of Cambridge · GBMRC Laboratory of Molecular Biology · GBWellcome Sanger Institute · GBCalifornia Institute of Technology · USUniversidade de São Paulo · BRWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Placental models to support embryogenesis in vitroDP1HD104575 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ZERNICKA-GOETZ, MAGDALENA · 2020 to 2024
$5.8M
Temporal program for cell fate specification in the mouse embryoR01HD100456 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Magdalena Zernicka-Goetz · 2020 to 2026
$3.3M
Biotechnology and Biological Sciences Research Council 1943755European Research Council 669198Medical Research Council MC_PC_17230Medical Research Council MC_UP_1201/24NICHD NIH HHS DP1 HD104575NICHD NIH HHS R01 HD100456Wellcome TrustWellcome Trust 207415/Z/17/Z
6 · The paper itself

Abstract

Human embryogenesis entails complex signalling interactions between embryonic and extra-embryonic cells. However, how extra-embryonic cells direct morphogenesis within the human embryo remains largely unknown due to a lack of relevant stem cell models. Here, we have established conditions to differentiate human pluripotent stem cells (hPSCs) into yolk sac-like cells (YSLCs) that resemble the post-implantation human hypoblast molecularly and functionally. YSLCs induce the expression of pluripotency and anterior ectoderm markers in human embryonic stem cells (hESCs) at the expense of mesoderm and endoderm markers. This activity is mediated by the release of BMP and WNT signalling pathway inhibitors, and, therefore, resembles the functioning of the anterior visceral endoderm signalling centre of the mouse embryo, which establishes the anterior-posterior axis. Our results implicate the yolk sac in epiblast cell fate specification in the human embryo and propose YSLCs as a tool for studying post-implantation human embryo development

Indexed as

AnimalsCell LineEctodermEmbryonic DevelopmentGerm LayersHumansMicePluripotent Stem CellsYolk Saccell biologydevelopmental biologyembryologyepiblasthumanhuman developmenthypoblastmousepluripotencystem cells

Identifiers

PMID34403333
PMCPMC8370770
OpenAlexW3195645878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.